TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36107219

Group type: EXPERIMENTAL
Intervention: RT boost (80 Gy to the boost subvolume)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Standard RT (70 Gy)
Number of subjects: 81
Study: 32822347

Group type: COMPARATOR
Intervention: Artemisinin-sensitive (ART-S) parasites
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Artemisinin-resistant (ART-R) parasites
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Artesunate (AS) 2 mg/kg oral dose
Number of subjects: 27
Study: 32651338

Group type: EXPERIMENTAL
Intervention: 7.5 mg Dalfampridine extended release (D-ER)
Number of subjects: 377

Group type: EXPERIMENTAL
Intervention: 10 mg Dalfampridine extended release (D-ER)
Number of subjects: 377

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 377
Study: 35971178

Group type: EXPERIMENTAL
Intervention: Online personalised parenting programme
Number of subjects: 433

Group type: COMPARATOR
Intervention: Online factsheets about adolescent development and wellbeing
Number of subjects: 433
Study: 32272171

Group type: EXPERIMENTAL
Intervention: Rapid phenotypic AST
Number of subjects: 116

Group type: COMPARATOR
Intervention: Conventional AST
Number of subjects: 116
Study: 35850588

Group type: EXPERIMENTAL
Intervention: Expressive art therapy (EAT) plus usual care (UC)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Usual care (UC) only
Number of subjects: 360
Study: 32865471

Group type: EXPERIMENTAL
Intervention: Fast-tempo music
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Slow-tempo music
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-music control
Number of subjects: 0
Study: 34699909

Group type: EXPERIMENTAL
Intervention: AIMS training
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: AIMS training - Inquire element
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: AIMS training - Mirror element
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: AIMS training - Secure element
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control training
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Self-confidence
Number of subjects: 53

Group type: COMPARATOR
Intervention: Standardized patient evaluations of communication skills
Number of subjects: 53
Study: 33685375

Group type: EXPERIMENTAL
Intervention: Depot medroxyprogesterone acetate injectable
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Levonorgestrel implant
Number of subjects: 97
Study: 32055629

Group type: EXPERIMENTAL
Intervention: Inhaled 0.9% normal saline by ultrasonic nebuliser with warming (UNW)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Oral expectorant treatment
Number of subjects: 27
Study: 36254010

Group type: EXPERIMENTAL
Intervention: Nurse-led program
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual-care group
Number of subjects: 150
Study: 32421163

Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention (24-week program)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 68
Study: 32690056

Group type: EXPERIMENTAL
Intervention: Surgery Simulation Teaching based on a Real Reconstruction Aid (RRA‐SST)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Traditional surgical live teaching
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: RRA‐SST
Number of subjects: 26
Study: 33279662

Group type: EXPERIMENTAL
Intervention: RT and placebo (PLA)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: RT and BCAA (9 g/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 30
Study: 32437857

Group type: EXPERIMENTAL
Intervention: Single impression with stock trays (irreversible hydrocolloid)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Two-step impression in custom trays with border molding (impression compound) followed by polyether impression
Number of subjects: 52
Study: 34936992

Group type: EXPERIMENTAL
Intervention: Education intervention
Number of subjects: 104
Study: 32993773

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 224

Group type: COMPARATOR
Intervention: Warfarin plus nadroparin
Number of subjects: 224
Study: 35566250

Group type: EXPERIMENTAL
Intervention: A. tricolor accessions
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: A. lividus accessions
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: A. tricolor and A. lividus accessions
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Accession AT2
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Accession AT5
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Accession AT12
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Correlation study
Number of subjects: 8
Study: 34765229

Group type: EXPERIMENTAL
Intervention: High-volume injection with corticosteroid
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: High-volume injection without corticosteroid
Number of subjects: 192

Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 192
Study: 35605593

Group type: EXPERIMENTAL
Intervention: Moxibustion plus acupuncture
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard stroke treatment protocol including acupuncture
Number of subjects: 60
Study: 33901276

Group type: EXPERIMENTAL
Intervention: Genetically-determined higher TSH in low BMI group
Number of subjects: 408895

Group type: EXPERIMENTAL
Intervention: Genetically-determined higher TSH
Number of subjects: 408895

Group type: EXPERIMENTAL
Intervention: Genetically-determined fT4 levels
Number of subjects: 408895
Study: 33122787

Group type: EXPERIMENTAL
Intervention: Posterior plate
Number of subjects: 15

Group type: COMPARATOR
Intervention: Anteroposterior (AP) lag screws
Number of subjects: 15

Group type: COMPARATOR
Intervention: Posteroanterior (PA) lag screws
Number of subjects: 15
Study: 34763236

Group type: EXPERIMENTAL
Intervention: 1.5 in. chest compression depth
Number of subjects: 40

Group type: COMPARATOR
Intervention: 1/3 the anterior‐posterior diameter (APd) chest compression depth
Number of subjects: 40
Study: 34106667

Group type: EXPERIMENTAL
Intervention: Acupoint catgut embedding before the operation
Number of subjects: 0

Group type: COMPARATOR
Intervention: No special treatment (Control group)
Number of subjects: 0
Study: 32427280

Group type: EXPERIMENTAL
Intervention: Oil-based contrast
Number of subjects: 140

Group type: COMPARATOR
Intervention: Water-based contrast
Number of subjects: 140
Study: 35422134

Group type: EXPERIMENTAL
Intervention: Screening Group (SG) - biennial prostate specific antigen testing
Number of subjects: 20000

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 20000
Study: 34452734

Group type: EXPERIMENTAL
Intervention: TACE with bleomycin
Number of subjects: 170

Group type: COMPARATOR
Intervention: TACE with doxorubicin
Number of subjects: 170
Study: 35902830

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus strain GG (LGG) probiotic supplementation
Number of subjects: 0
Study: 33507839

Group type: EXPERIMENTAL
Intervention: Cold Water Immersion (CWI)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 29
Study: 33348678

Group type: EXPERIMENTAL
Intervention: FTO rs9939609 A‐allele (AA)
Number of subjects: 24

Group type: COMPARATOR
Intervention: FTO rs9939609 T‐allele (TT)
Number of subjects: 24
Study: 35326326

Group type: EXPERIMENTAL
Intervention: Chlorogenic acids (CGA) 270 mg
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 26
Study: 33669905

Group type: EXPERIMENTAL
Intervention: Higher cardiorespiratory fitness (CRF)
Number of subjects: 832

Group type: EXPERIMENTAL
Intervention: Higher physical activity (PA)
Number of subjects: 832

Group type: EXPERIMENTAL
Intervention: CRF/PA quartiles
Number of subjects: 832
Study: 36501148

Group type: EXPERIMENTAL
Intervention: Beetroot juice (BJ)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 32701188

Group type: EXPERIMENTAL
Intervention: Tegoprazan 50 mg
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Tegoprazan 100 mg
Number of subjects: 306

Group type: COMPARATOR
Intervention: Lansoprazole 30 mg
Number of subjects: 306
Study: 36342251

Group type: EXPERIMENTAL
Intervention: Microneedling followed by 35% glycolic acid (GA) peel
Number of subjects: 40

Group type: COMPARATOR
Intervention: Microneedling followed by 15% trichloroacetic acid (TCA) peel
Number of subjects: 40
Study: 33201029

Group type: EXPERIMENTAL
Intervention: WeChat-based PISQ-12 questionnaire
Number of subjects: 120

Group type: COMPARATOR
Intervention: Paper version of PISQ-12 questionnaire
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: WeChat questionnaire
Number of subjects: 120
Study: 35583992

Group type: EXPERIMENTAL
Intervention: HIPEC with cisplatin
Number of subjects: 245
Study: 35640081

Group type: EXPERIMENTAL
Intervention: Preventive programs (intervention group)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Routine oral health education (control group)
Number of subjects: 36
Study: 32251254

Group type: EXPERIMENTAL
Intervention: TENS + TE
Number of subjects: 90

Group type: COMPARATOR
Intervention: TE alone
Number of subjects: 90
Study: 34750670

Group type: EXPERIMENTAL
Intervention: Intra wound vancomycin (1-2 g)
Number of subjects: 375

Group type: COMPARATOR
Intervention: No drug (control group)
Number of subjects: 375
Study: 34538239

Group type: EXPERIMENTAL
Intervention: Daily clinical warning signs (CWS) assessment
Number of subjects: 843

Group type: EXPERIMENTAL
Intervention: Daily risk scores using 7 CWS and MUAC<10.5cm
Number of subjects: 843

Group type: EXPERIMENTAL
Intervention: Counting top 5 CWS
Number of subjects: 843

Group type: EXPERIMENTAL
Intervention: Presence of 1 or 2 CWS on any day during hospitalization
Number of subjects: 843
Study: 32701242

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine combined with protective ventilation strategy (DF group; n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pulmonary protective ventilation strategy (F group)
Number of subjects: 40
Study: 35359485

Group type: EXPERIMENTAL
Intervention: Aerosol box (AB) with PPE
Number of subjects: 40

Group type: COMPARATOR
Intervention: PPE alone (Control)
Number of subjects: 40
Study: 34016139

Group type: EXPERIMENTAL
Intervention: Three-dimensional printing individual guide template-assisted percutaneous vertebroplasty (group A)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional PVP guided by C-arm fluoroscopy (group B)
Number of subjects: 36
Study: 34689382

Group type: EXPERIMENTAL
Intervention: Pemetrexed/cisplatin (Pem/Cis)
Number of subjects: 389

Group type: COMPARATOR
Intervention: Vinorelbine/cisplatin (Vnr/Cis)
Number of subjects: 389
Study: 35841050

Group type: EXPERIMENTAL
Intervention: Vitamin D levels
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (sex and age matched)
Number of subjects: 60
Study: 34548307

Group type: EXPERIMENTAL
Intervention: Trastuzumab deruxtecan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Trastuzumab emtansine
Number of subjects: 0
Study: 35587794

Group type: EXPERIMENTAL
Intervention: Moving gratings combined with standard occlusion
Number of subjects: 37

Group type: COMPARATOR
Intervention: Stationary gratings combined with standard occlusion
Number of subjects: 37
Study: 34811410

Group type: EXPERIMENTAL
Intervention: Process-simulation with elements of relaxation
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Outcome-simulation with elements of relaxation
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group with elements of relaxation only
Number of subjects: 150
Study: 35562821

Group type: EXPERIMENTAL
Intervention: HIV risk reduction intervention
Number of subjects: 20
Study: 33185043

Group type: EXPERIMENTAL
Intervention: New technique for laparoscopic para-aortic lymphadenectomy (PAL)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control method for laparoscopic para-aortic lymphadenectomy (PAL)
Number of subjects: 37
Study: 32760749

Group type: EXPERIMENTAL
Intervention: Beating the Blues US (BtB) - 8-session internet cognitive-behavioral therapy for depression
Number of subjects: 54

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 54
Study: 35270810

Group type: EXPERIMENTAL
Intervention: New model of providing preventive care (healthy choices consultation, embedding risk factors into care plans, continuation of preventive care by mental health clinicians)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 12
Study: 33085516

Group type: EXPERIMENTAL
Intervention: Purified lycopene (LYC) supplementation at 20 mg/kg diet for 12 weeks
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Tomato powder (TP) supplementation at an equal amount of lycopene for 12 weeks
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard diet (control)
Number of subjects: 150
Study: 33201059

Group type: EXPERIMENTAL
Intervention: Topical fluorometholone (FML)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Topical cyclosporine A (CSA) 0.5% eye drops
Number of subjects: 72
Study: 32044755

Group type: COMPARATOR
Intervention: Facebook posts
Number of subjects: 211

Group type: COMPARATOR
Intervention: Facebook posts plus text messages
Number of subjects: 211

Group type: COMPARATOR
Intervention: Control group (electronic leaflet)
Number of subjects: 211
Study: 33293079

Group type: EXPERIMENTAL
Intervention: Concomitant radiotherapy with chemotherapy (cRT)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Radiotherapy without concomitant chemotherapy (RT)
Number of subjects: 117
Study: 33023501

Group type: EXPERIMENTAL
Intervention: Community outreach
Number of subjects: 105

Group type: COMPARATOR
Intervention: GP letters
Number of subjects: 105
Study: 36177347

Group type: EXPERIMENTAL
Intervention: Tenofovir Disoproxil (TD) 245 mg
Number of subjects: 189

Group type: COMPARATOR
Intervention: Tenofovir Disoproxil Fumarate (TDF) 300 mg
Number of subjects: 189
Study: 33676866

Group type: EXPERIMENTAL
Intervention: Latissimus dorsi (LD) flap
Number of subjects: 50

Group type: COMPARATOR
Intervention: Thoracodorsal artery perforator (TAP) flap
Number of subjects: 50
Study: 32171731

Group type: EXPERIMENTAL
Intervention: Stapler device
Number of subjects: 70

Group type: COMPARATOR
Intervention: Electrocautery
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 70
Study: 35643710

Group type: EXPERIMENTAL
Intervention: rivaroxaban
Number of subjects: 0

Group type: COMPARATOR
Intervention: no treatment
Number of subjects: 0
Study: 32294276

Group type: EXPERIMENTAL
Intervention: Fat mass index
Number of subjects: 367703

Group type: EXPERIMENTAL
Intervention: Fat-free mass index
Number of subjects: 367703
Study: 35641971

Group type: EXPERIMENTAL
Intervention: Multi-component workplace interventions targeting sedentary behavior or increasing physical activity
Number of subjects: 263

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 263
Study: 33200722

Group type: EXPERIMENTAL
Intervention: MDT for leprosy (600 mg rifampicin, 300 mg clofazimine, 100 mg dapsone monthly; 50 mg clofazimine and 100 mg dapsone daily)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: MDT for leprosy plus itraconazole (100 mg twice daily)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (patients who did not adhere to therapeutic regimens)
Number of subjects: 103
Study: 32185477

Group type: EXPERIMENTAL
Intervention: Interval training in hypoxia (IHT)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Repeated sprint training in hypoxia (RSH)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Interval training in normoxia (INT)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Repeated sprint training in normoxia (RSN)
Number of subjects: 82
Study: 33596993

Group type: EXPERIMENTAL
Intervention: Metformin (850 mg p.o. twice/day)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Fermentable fibers (35 g/day)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Combination of metformin plus fiber
Number of subjects: 100
Study: 33163157

Group type: EXPERIMENTAL
Intervention: Routinely collected health data (RCHD)
Number of subjects: 216
Study: 34955237

Group type: EXPERIMENTAL
Intervention: Total Laparoscopic Hysterectomy (TLH)
Number of subjects: 279

Group type: COMPARATOR
Intervention: Total Abdominal Hysterectomy (TAH)
Number of subjects: 279
Study: 33603000

Group type: EXPERIMENTAL
Intervention: Modified Dietary Approaches to Stop Hypertension (DASH) diet
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: DASH and exercise group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 32182380

Group type: EXPERIMENTAL
Intervention: PR/RP+EMD
Number of subjects: 50

Group type: COMPARATOR
Intervention: PR/RP+saline
Number of subjects: 50
Study: 36155536

Group type: EXPERIMENTAL
Intervention: Trunk stabilization exercise program using weight loads
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Trunk stabilization exercise program
Number of subjects: 30

Group type: COMPARATOR
Intervention: General physiotherapy
Number of subjects: 30
Study: 34674404

Group type: EXPERIMENTAL
Intervention: Scheduled anticonvulsants and benzodiazepines as needed
Number of subjects: 75

Group type: COMPARATOR
Intervention: Usual care (benzodiazepines as needed)
Number of subjects: 75
Study: 32122951

Group type: EXPERIMENTAL
Intervention: Humorous digital media attention diversion (watching humorous movies)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Non-humorous digital media attention diversion (watching non-humorous movies)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Humorous digital media attention diversion
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Non-humorous digital media attention diversion
Number of subjects: 66
Study: 36114824

Group type: EXPERIMENTAL
Intervention: Hemp seed
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Hemp seed + PA
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: PA
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 33963984

Group type: EXPERIMENTAL
Intervention: Health promotion intervention targeting self-efficacy
Number of subjects: 270
Study: 32376080

Group type: EXPERIMENTAL
Intervention: Problem Solving Therapy (PST)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Engage therapy
Number of subjects: 32
Study: 36044093

Group type: EXPERIMENTAL
Intervention: Intravenous ferric carboxymaltose
Number of subjects: 11
Study: 34081034

Group type: EXPERIMENTAL
Intervention: Paratracheal pressure
Number of subjects: 140

Group type: COMPARATOR
Intervention: Cricoid pressure
Number of subjects: 140
Study: 36102618

Group type: EXPERIMENTAL
Intervention: Lung volume recruitment (LVR) used twice-daily
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: LVR
Number of subjects: 11
Study: 34343033

Group type: EXPERIMENTAL
Intervention: Avapritinib 300 mg once daily (4 weeks continuously)
Number of subjects: 476

Group type: COMPARATOR
Intervention: Regorafenib 160 mg once daily (3 weeks on and 1 week off)
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Avapritinib
Number of subjects: 476

Group type: COMPARATOR
Intervention: Regorafenib
Number of subjects: 476
Study: 32600363

Group type: EXPERIMENTAL
Intervention: Pantoprazole (9-day course)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no pantoprazole)
Number of subjects: 24
Study: 36273187

Group type: EXPERIMENTAL
Intervention: online CBT modules with asynchronous therapist feedback
Number of subjects: 1000

Group type: COMPARATOR
Intervention: usual care
Number of subjects: 1000
Study: 32699049

Group type: EXPERIMENTAL
Intervention: Femtosecond laser-assisted cataract surgery (FLACS)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Conventional phacoemulsification surgery (CPS)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Intrastromal femtosecond laser-assisted astigmatic keratotomies (iFAKs)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Manual limbal relaxing incisions (LRIs)
Number of subjects: 400
Study: 34916330

Group type: EXPERIMENTAL
Intervention: Integrated intervention (INT)
Number of subjects: 631

Group type: COMPARATOR
Intervention: Improved mental healthcare (MHC)
Number of subjects: 631

Group type: COMPARATOR
Intervention: Service as usual (SAU)
Number of subjects: 631

Group type: EXPERIMENTAL
Intervention: Integrated intervention (INT) and Improved mental healthcare (MHC)
Number of subjects: 631
Study: 32873354

Group type: EXPERIMENTAL
Intervention: PUFA products
Number of subjects: 17

Group type: COMPARATOR
Intervention: SFA products (control)
Number of subjects: 17
Study: 33103950

Group type: EXPERIMENTAL
Intervention: Dyslipidemia in PALS
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: Hypercholesterolemia
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: Mixed dyslipidemia
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: Triacylglycerols (TAG) and LDL/HDL
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: LDL/HDL and total cholesterol (TCh)
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: Total cholesterol (TCh)
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: TAG
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: Lipid parameters
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: Classic ALS and PMA
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: PBP
Number of subjects: 650
Study: 35166190

Group type: EXPERIMENTAL
Intervention: ICCMS
Number of subjects: 240

Group type: COMPARATOR
Intervention: CCMS
Number of subjects: 240
Study: 34496899

Group type: COMPARATOR
Intervention: Methylphenidate (MPH), administered twice daily, dosage based on age and body weight.
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 37823711

Group type: EXPERIMENTAL
Intervention: 12% caloric restriction (CR) for 2 years
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (ad libitum)
Number of subjects: 90
Study: 33446270

Group type: EXPERIMENTAL
Intervention: Spinal manipulative therapy followed by physiotherapeutic scoliosis-specific exercise (PSSE)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Physiotherapeutic scoliosis-specific exercise (PSSE) alone
Number of subjects: 40
Study: 32182615

Group type: EXPERIMENTAL
Intervention: Closed vitrification system
Number of subjects: 190

Group type: COMPARATOR
Intervention: Open vitrification system
Number of subjects: 190
Study: 33589575

Group type: EXPERIMENTAL
Intervention: Prognostic model based on 5 pivotal RBP genes (RNASE2, METTL1, ANG, YBX2, LARP6)
Number of subjects: 806

Group type: EXPERIMENTAL
Intervention: Prognostic nomogram developed from the model
Number of subjects: 806
Study: 32564920

Group type: EXPERIMENTAL
Intervention: Intravitreal sirolimus 440 μg
Number of subjects: 592

Group type: COMPARATOR
Intervention: Intravitreal sirolimus 44 μg
Number of subjects: 592

Group type: EXPERIMENTAL
Intervention: Intravitreal sirolimus 880 μg
Number of subjects: 592